Apotex alleged that specified US courtroom judgments and FDA decisions discriminated in opposition to it, denied it least common of treatment and expropriated its expenditure in pravastatin. Damages sought: US£8 million.Dow even more alleged which the ban is 'tantamount to expropriation'. Damages sought: more than US£twelve million. scenario as b… Read More